Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oramed Pharmaceuticals (ORMP) has provided an announcement.
David Silberman has stepped down from his roles as CFO, Treasurer, and Secretary at Oramed Pharmaceuticals Inc. for personal reasons, with his resignation effective from July 12, 2024. The company is actively looking for a new CFO to fill the vacancy.
Find detailed analytics on ORMP stock on TipRanks’ Stock Analysis page.
